Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Beam Therapeutics Inc (NASDAQ: BEAM) closed the day trading at $24.53 up 4.65% from the previous closing price of $23.44. In other words, the price has increased by $4.65 from its previous closing price. On the day, 0.8 million shares were traded. BEAM stock price reached its highest trading level at $24.6 during the session, while it also had its lowest trading level at $23.5359.
Ratios:
For a better understanding of BEAM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.69 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on November 06, 2024, Upgraded its rating to Outperform and sets its target price to $39 from $27 previously.
On July 23, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.H.C. Wainwright initiated its Buy rating on July 23, 2024, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’25 when Bellon Christine sold 1,241 shares for $24.68 per share. The transaction valued at 30,628 led to the insider holds 102,968 shares of the business.
Cavanagh Bethany J sold 1,117 shares of BEAM for $27,568 on Jan 02 ’25. The SVP, Finance and Treasurer now owns 43,814 shares after completing the transaction at $24.68 per share. On Dec 31 ’24, another insider, BETHANY J. CAVANAGH, who serves as the Officer of the company, bought 9,500 shares for $25.27 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2031221376 and an Enterprise Value of 1188706176. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.81 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 3.4 whereas that against EBITDA is -7.391.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -7.33%, while the 200-Day Moving Average is calculated to be -2.69%.
Shares Statistics:
Over the past 3-months, BEAM traded about 1.21M shares per day on average, while over the past 10 days, BEAM traded about 1404360 shares per day. A total of 82.56M shares are outstanding, with a floating share count of 72.58M. Insiders hold about 12.35% of the company’s shares, while institutions hold 81.95% stake in the company. Shares short for BEAM as of 1735603200 were 9830125 with a Short Ratio of 8.13, compared to 1732838400 on 10678009. Therefore, it implies a Short% of Shares Outstanding of 9830125 and a Short% of Float of 15.529999.
